Lawmakers make major improvements to cannabis policy in 2019.
Gov. Steve Sisolak (D) signed into law three notable bills to improve cannabis policies this year. Here is a quick overview and why they are so important:
AB 132 prohibits most employers from denying applicants a job if cannabis shows up on a pre-employment drug test. This bill addresses a big concern — cannabis use can be detected for weeks after ingestion, meaning drug screens in no way correlate with impairment. So far, states have been generally unwilling to change employment standards, even when cannabis use is legal outside work hours. This bill is a major development for Nevadans, and MPP wants to see other states take notice.
SB 430 was signed into law last week and expands the list of qualifying conditions for medical cannabis. The bill adds forms of autism, anxiety, and chronic pain — in addition to severe pain, which was already included. A key addition were those individuals who are "dependent upon or addicted to opioids," making medical cannabis an alternative to anyone at risk while taking prescription narcotic medication. This is part of a trend we see around the country, and it's great to see Nevada added to the list of states offering this important alternative.
AB 192 allows individuals to have their past convictions sealed if the conduct — such as marijuana possession — has been legalized or decriminalized. While this is not as expansive as completely removing the conviction, sealing can significantly reduce the stigma and collateral consequences lingering from the failed war on cannabis.
MPP is proud to have led Nevada's legalization initiative in 2016 and important improvements to the medical cannabis law in 2013. Today, lawmakers are making sensible improvements to those programs, and more importantly, the medical and adult-use programs continue to serve the state and its residents.
On Monday, September 24, Gov. Andrew Cuomo signed a bill that adds acute pain management to the list of approved conditions eligible for treatment with medical marijuana as an alternative to opioid use. This new law formalizes regulations the New York State Department of Health issued in July, which added opioid replacement and opioid use disorder to the list.
This is great news for patients! Access to medical marijuana is no longer limited to those suffering from chronic pain. This bill and regulations allow more patients who could benefit from medical marijuana a safe and effective alternative to highly addictive opioids.
Find more information on New York’s medical marijuana program, including the list of qualifying conditions and how to register, here.
Illinois governor signs opioid alternative bill, making huge improvements to medical cannabis program
Sweeping changes include medical cannabis access for opioid patients, streamlined process, and others
Illinois’s medical cannabis program took a major step forward today as Gov. Bruce Rauner signed bill SB 336, the Alternatives to Opioids Act, into law.
This historic change makes several key improvements:
• Opioid patients now qualify. Patients who are — or could be — prescribed opioid drugs will be able to register to obtain medical cannabis as an alternative.
• Shorter wait times. Patients will get provisional authorization to access medical cannabis as soon as their paperwork is submitted for registration — saving weeks of wait time.
• No more fingerprint requirement! Patients and caregivers will no longer be required to submit fingerprints to register for the program, and those with felony convictions in their past will no longer be denied access to the program.
Many thanks go to bill sponsors Sen. Don Harmon and Rep. Kelly Cassidy, and the many medical cannabis patients and supporters who worked to pass this major improvement to state law. The full text of the measure is here.
In other news, if you are in the neighborhood, the public is invited to tonight’s town hall on cannabis legalization for adults in La Grange, Illinois.
When: Tuesday, August 28 7:00 p.m.
Where: La Grange Village Hall Auditorium, 53 S. La Grange Road, La Grange, Illinois
Who: Bill sponsor Sen. Heather Steans, Rep. Jim Durkin, and several other panelists
Another big win for medical cannabis patients today — please spread the word! And if you can, come to tonight’s town hall and support a sensible legalization law in Illinois!
Earlier this year, the Hawaii Legislature overwhelmingly approved SB 2407, which would allow opioid and substance use disorders, and their symptoms, to be treated with medical cannabis if a physician recommends it. But last week, Gov. David Ige announced he intends to veto this compassionate bill.
Medical cannabis can ease the devastating symptoms of opiate withdrawal and make it easier for individuals to stay on treatment regimens. For some, this is an issue of life or death.
The governor has until July 10 to act on the bill. If you are a resident of Hawaii, please call Gov. Ige at 808-586-0034 or send him an email to urge him to reconsider. We’ve provided some talking points and a draft email message to make the process easy.
The Health Commissioner of New York, Howard Zucker, recently announced that a long-awaited study by the Cuomo administration will recommend the legalization and regulation of marijuana for adult use. The study is believed to be at least partly in response to gubernatorial primary candidate Cynthia Nixon’s strong support of marijuana legalization.
Mr. Zucker also announced that the Health Department will issue regulations to allow patients who have been prescribed opioids to qualify for the state’s medical marijuana program. Not all patients can qualify under the existing chronic pain provision, since opioids may also be prescribed for severe but short-term pain, such as after surgery. The New York Senate also passed a bill to do the same, as well as to allow patients with opioid use disorder to qualify.
While the state’s legislative session is ending soon, New York is moving closer to ending marijuana prohibition!
In other news, New York City Mayor Bill DiBlasio, under increasing pressure to address the racial disparity in low-level marijuana arrests, announced a new policy designed to reduce arrests and give more tickets instead. Unfortunately, the policy, which will take effect September 1, has so many exceptions its impact may be limited.
The Illinois General Assembly passed the Opioid Alternative Pilot Program Act yesterday during a whirlwind last day of its regular legislative session. If signed into law, SB 336 would allow those who could be prescribed opioid drugs to qualify for the medical cannabis program. It also dramatically improves current law by streamlining wait times and removing fingerprint requirements for patients.
This bill would provide welcome relief to thousands who need a safer alternative to harmful opioid drugs. For a summary written by bill supporters — including key changes to background checks and shortened approval process — click here. The final bill draft language is here.
A huge shout-out goes to the medical cannabis community, the warriors who worked so hard to make it happen, and primary bill sponsors, Sen. Don Harmon and Rep. Kelly Cassidy, and co-sponsors for their leadership and support. Thousands of lives could improve as a result.
But without the governor’s signature, it won’t become a reality. Gov. Rauner has 60 days from the day he receives it to sign or veto the measure, and he needs to hear from you. If you are an Illinois resident, please take a moment to voice your support for the measure with the governor’s office.
The Illinois House of Representatives may soon vote on SB 336, which would allow those who could be prescribed opioid drugs to qualify for the Medical Cannabis Pilot Program. Last month, the Senate passed the measure by a wide margin, but its future in the House is less certain.
While opioids can be highly addictive and dangerous, many seriously ill patients across the country are opting for a safer alternative. Medical cannabis has emerged as an effective option for hundreds of thousands of patients around the U.S. Yet, Illinois’ medical cannabis law does not include pain as a qualifying condition. It’s past time to allow patients to use cannabis instead of opiate-based medications.
Another bill which would also provide patients welcome relief passed both chambers and is now on Gov. Bruce Rauner’s desk. If signed, HB 4870 would allow students who are registered patients to access medical cannabis at school under certain circumstances. While limited, it is an important improvement to ensure patients do not have to choose between their health and their education. If you are an Illinois resident, call Gov. Rauner at (217) 782-0244 and ask him to sign this important bill into law.
Yesterday, Gov. Phil Murphy held a press conference to announce numerous changes to the medical marijuana program in New Jersey that will greatly improve patient access. These include:
- Approving additional qualifying conditions under a process that was begun in 2016 — including chronic pain and opioid use disorder — which will help reduce opioid dependence and overdose.
- Setting up a process to add additional businesses and remove the vertical integration requirement, which will increase competition and therefore reduce prices for patients.
- Eliminating the physician registry, so that all doctors who wish to do so can recommend medical cannabis to their patients without jumping through hoops.
- Removing the 10% THC cap imposed by regulation, because some patients need products with more THC for the most effective treatment.
In addition, the Department of Health’s report recommended additional changes, which would have to be made by the legislature. These include increasing the amount of cannabis that patients can purchase each month and allowing patients of all ages to purchase edibles if that’s their preferred delivery method.
You can read the Department of Health's full report here. MPP will continue to work with the administration as it implements these changes,
Illinois State Sen. Dan Harmon is championing a bill that would allow individuals who are prescribed opioids to qualify for access to medical cannabis. His bill, SB 336, is expected to receive a hearing tomorrow in the Senate Executive Committee.
Hundreds of thousands of people are prescribed opioids in Illinois. These drugs carry a very high risk of dependency, and they can cause significant long-term harm including the risk of overdose death. Medical cannabis is now providing relief around the country and reducing incidents of drug ovedose deaths where it is available. But Illinois is one of only three medical marijuana states where pain patients don’t qualify, unless they have a specifically listed disease.
This bill would also take the sensible step of removing the requirement that medical cannabis patients submit fingerprints, provided they qualify under the new provisions. It is a huge first step for the many Illinoisans suffering unbearable pain every day.
If you are an Illinois resident, please tell your senator to support SB 336 and vote “yes” if it is placed before the senator for a vote.
New Hampshire’s therapeutic cannabis law is finally expanding to include patients who suffer from chronic pain. HB 157 went into effect on Tuesday, adding “moderate to severe chronic pain” as a qualifying condition. This new law will allow many more Granite Staters to use cannabis as an alternative to prescribed opioids — a critically important reform for a state that is struggling to turn the tide against opiate addiction.
Until this week, patients could only qualify with a pain diagnosis if their pain was deemed to be “severe” and related to one of the specific medical conditions provided for in the law. As a result, it was much easier for medical providers to prescribe opioids than to certify patients for therapeutic cannabis. Patients who would like to apply now that the law has changed can access the updated application forms here.
For those who are waiting for the addition of post-traumatic stress disorder (PTSD), that is scheduled to take effect on August 27.